Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management

NCT04385108 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04385108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
March 4, 2020
Completion date
December 24, 2021
Enrollment
565 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19